Jacqui M. Hall

Contracts Manager

Novartis Pharmaceuticals Corporation

• Handled a broad range of transactions including licensing of biotechnology and software technologies
• Helped develop internal guidance on negotiating clinical trial agreements

In-house Counsel

Millennium Pharmaceuticals, Inc. (now Takeda Pharmaceutical Company Limited)

• Handled a broad range of transactions including licensing of biotechnology and software technologies
• Drafted a variety of consulting agreements, and service and manufacturing agreements

• Counseled ex-U.S. portfolio company on its services agreement with ex-US CDMO for IND-enabling development and GMP manufacture of drug substance, and associated cell line license agreement, including royalty and milestone payment structure.
• Regularly advises clients ranging from early stage to those with marketed product on their services/supply agreements for development and manufacture of GMP material, including biologics.
• Drafted and negotiated multiple in-licenses of patent rights from top academic U.S. institution on behalf of major Boston-based venture capital backed portfolio companies.
• Represents clients on sponsored research agreements and MTAs with academic institutions in U.S. and ex-U.S. for research using client proprietary materials.
• Strategically counsels clients on agreements for client evaluation of proprietary industry materials and intellectual property.
• Represented UK-based client transitioning to a clinical stage company on a SaaS agreement for a data analytics platform.